Y. Roux, C. Guimart, and M. Tenenhaus. European journal of drug metabolism and pharmacokinetics, 23 (2):
339-45(1998)2478<m:linebreak></m:linebreak>Tests d'equivalència.
K. Janssen, K. Moons, C. Kalkman, D. Grobbee, and Y. Vergouwe. Journal of clinical epidemiology, 61 (1):
76-86(January 2008)4731<br/>JID: 8801383; 2006/08/22 received; 2007/03/08 revised; 2007/04/20 accepted; 2007/11/26 aheadofprint; ppublish;<br/>Models predictius; Avaluació de riscs.
L. Inoue, R. Gulati, C. Yu, M. Kattan, and R. Etzioni. Biostatistics (Oxford, England), 14 (1):
15-27(January 2013)7099<m:linebreak></m:linebreak>JID: 100897327; 2012/06/22 aheadofprint; aheadofprint; Bona gràfica per explicar els lead times segons el moment del diagnòstic.
K. Flegal, B. Graubard, and D. Williamson. American journal of epidemiology, 160 (4):
331-8(August 2004)4391<m:linebreak></m:linebreak>LR: 20041117; PUBM: Print; JID: 7910653; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.